A Phase 2, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis.

  • Wilson, John (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date30/05/19 → 29/02/20

Keywords

  • Cystic fibrosis
  • Allergy
  • Immunology
  • Clinical trial